| NDC Code | 60687-509-25 |
|---|
| Package Description | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-509-25) > 1 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK (60687-509-95) |
|---|
| Product NDC | 60687-509 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, Amphetamine Sulfate |
|---|
| Non-Proprietary Name | Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, Amphetamine Sulfate |
|---|
| Dosage Form | CAPSULE, EXTENDED RELEASE |
|---|
| Usage | ORAL |
|---|
| Start Marketing Date | 20200710 |
|---|
| End Marketing Date | 20230630 |
|---|
| Marketing Category Name | ANDA |
|---|
| Application Number | ANDA206159 |
|---|
| Manufacturer | American Health Packaging |
|---|
| Substance Name | AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE |
|---|
| Strength | 5; 5; 5; 5 |
|---|
| Strength Unit | mg/1; mg/1; mg/1; mg/1 |
|---|
| Pharmacy Classes | Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE] |
|---|
| DEA Schedule | CII |
|---|